If you check some of the posters in our link library (cognitive study), you'll see that RVX 208 helps to protect the endothelial system in our bodies.  So Apabetalone could also benefit patients who are experiencing acute respiratory distress syndrome (danger of multiple organ failure) by inhibiting damage to your endothelial cells.  This is in adition to - or related to - Apabetalone's ability to inhibit the onset of cytokine release syndrome (cytokine storm)...again, check out the other posters that detail the effect of RVX 208 when it comes to inhibiting IL 6 and other markers.

https://www.nature.com/articles/s41577-020-0343-0

I am biased, but I believe Apabetalone has a therapeutic role to play in the treatment of very sick COVID 19 patients.   Justin!!!  give us some money for a study!!